{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:22:42Z","timestamp":1776201762455,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","funder":[{"name":"Takeda Pharmaceuticals International, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12325-016-0393-7","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T03:45:45Z","timestamp":1470800745000},"page":"1715-1727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gastroenterologists\u2019 Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale Survey"],"prefix":"10.1007","volume":"33","author":[{"given":"Karen","family":"Lasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyann","family":"Ursos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema","family":"Mody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"King-Concialdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"DiBonaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Leberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla","family":"Dubinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"key":"393_CR1","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/gut.2010.218180","volume":"60","author":"T Ochsenk\u00fchn","year":"2011","unstructured":"Ochsenk\u00fchn T, D\u2019Haens G. Current misunderstandings in the management of ulcerative colitis. Gut. 2011;60:1294\u20139.","journal-title":"Gut"},{"key":"393_CR2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.MIB.0000218762.61217.4a","volume":"12","author":"T Bernklev","year":"2006","unstructured":"Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:402\u201312.","journal-title":"Inflamm Bowel Dis"},{"key":"393_CR3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10620-012-2371-5","volume":"58","author":"MD Kappelman","year":"2013","unstructured":"Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn\u2019s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2013;58:519\u201325.","journal-title":"Dig Dis Sci"},{"key":"393_CR4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","volume":"44","author":"IC Solberg","year":"2009","unstructured":"Solberg IC, Lygren I, Jahnsen J, Aadland E, Hoie O, Cvancarova M, et al. Clinical course during the first 10\u00a0years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431\u201340.","journal-title":"Scand J Gastroenterol"},{"key":"393_CR5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","volume":"19","author":"MW Lutgens","year":"2013","unstructured":"Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19:789\u201399.","journal-title":"Inflamm Bowel Dis"},{"key":"393_CR6","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/ibd.22839","volume":"18","author":"J Torres","year":"2012","unstructured":"Torres J, Billioud V, Sachar DB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis as a progressive disease: the forgotten evidence. Inflamm Bowel Dis. 2012;18:1356\u201363.","journal-title":"Inflamm Bowel Dis"},{"key":"393_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gutjnl-2012-302311","volume":"62","author":"ML H\u00f8ivik","year":"2013","unstructured":"H\u00f8ivik ML, Moum B, Solberg IC, Henriksen M, Cvancarova M, Bernklev T, et al. Work disability in inflammatory bowel disease patients 10\u00a0years after disease onset: results from the IBSEN Study. Gut. 2013;62:368\u201375.","journal-title":"Gut"},{"key":"393_CR8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ajg.2012.127","volume":"107","author":"LE Targownik","year":"2012","unstructured":"Targownik LE, Singh H, Nugent Z, Bernstein CN. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol. 2012;107:1228\u201335.","journal-title":"Am J Gastroenterol"},{"key":"393_CR9","unstructured":"Peyrin-Biroulet L, Patel AS, Lindsay JO. Colectomy is not a cure for ulcerative colitis: a systematic review (P403). https:\/\/www.ecco-ibd.eu\/index.php\/publications\/congress-abstract-s\/abstracts-2015\/item\/p403-colectomy-is-not-a-cure-for-ulcerative-colitis-a-systematic-review.html . Accessed March 5, 2015."},{"key":"393_CR10","doi-asserted-by":"crossref","first-page":"S484","DOI":"10.1038\/ajg.2014.52","volume":"109","author":"K Lasch","year":"2014","unstructured":"Lasch K, Ursos L, Liu S, Mody R, Concialdi K, DiBonaventura M, et al. Understanding attitudes, perceptions, and beliefs about ulcerative colitis among gastroenterologists: phase 1 survey results (abstract 1631). Am J Gastroenterol. 2014;109:S484.","journal-title":"Am J Gastroenterol"},{"key":"393_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.gtc.2014.05.004","volume":"43","author":"J Jones","year":"2014","unstructured":"Jones J, Pe\u00f1a-S\u00e1nchez JN. Who should receive biologic therapy for IBD? The rationale for the application of a personalized approach. Gastroenterol Clin North Am. 2014;43:425\u201340.","journal-title":"Gastroenterol Clin North Am"},{"key":"393_CR12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","volume":"105","author":"A Kornbluth","year":"2010","unstructured":"Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501\u201323.","journal-title":"Am J Gastroenterol"},{"key":"393_CR13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.gtc.2014.05.006","volume":"43","author":"MA Samaan","year":"2014","unstructured":"Samaan MA, Bagi P, Vande Casteele N, D\u2019Haens GR, Levesque BG. An update on anti-TNF agents in ulcerative colitis. Gastroenterol Clin North Am. 2014;43:479\u201394.","journal-title":"Gastroenterol Clin North Am"},{"key":"393_CR14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s10620-009-0953-7","volume":"55","author":"DT Rubin","year":"2010","unstructured":"Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, et al. The impact of ulcerative colitis on patients\u2019 lives compared to other chronic diseases: a patient survey. Dig Dis Sci. 2010;55:1044\u201352.","journal-title":"Dig Dis Sci"},{"key":"393_CR15","unstructured":"Hofmann R, Guillaume X. Current views and concerns of European UC patients based on an online survey (P690). https:\/\/www.ecco-ibd.eu\/index.php\/publications\/congress-abstract-s\/abstracts-2015\/item\/p690-current-views-and-concerns-of-european-uc-patients-based-on-an-online-survey.html . Accessed March 5, 2015."},{"key":"393_CR16","unstructured":"Carpio D, Arg\u00fcelles F, Calvet X, Juli\u00e1 B, Romero C, L\u00f3pez-Sanrom\u00e1n A. Perception of social and emotional impact of ulcerative colitis by Spanish patients\u2014UC-life survey (P645). https:\/\/www.ecco-ibd.eu\/index.php\/publications\/congress-abstract-s\/abstracts-2015\/item\/p645-perception-of-social-and-emotional-impact-of-ulcerative-colitis-by-spanish-patients-uc-life-survey.html . Accessed March 5, 2015."},{"key":"393_CR17","unstructured":"L\u00f3pez-Sanrom\u00e1n A, Carpio D, Calvet X, Cea-Calvo L, Romero C, Arg\u00fcelles F. Perception about disease activity and treatment attributes in patients with ulcerative colitis from Spain\u2014UC-life survey (P670). https:\/\/www.ecco-ibd.eu\/index.php\/publications\/congress-abstract-s\/abstracts-2015\/item\/p670-perception-about-disease-activity-and-treatment-attributes-in-patients-with-ulcerative-colitis-from-spain-uc-life-survey.html . Accessed March 5, 2015."},{"key":"393_CR18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ibd.20793","volume":"15","author":"DT Rubin","year":"2009","unstructured":"Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, et al. Impact of ulcerative colitis from patients\u2019 and physicians\u2019 perspectives: results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009;15:581\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"393_CR19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.dld.2014.04.004","volume":"46","author":"C Duchesne","year":"2014","unstructured":"Duchesne C, Faure P, Kohler F, Pingannaud MP, Bonnaud G, Devulder F, et al. Management of inflammatory bowel disease in France: a nationwide survey among private gastroenterologists. Dig Liver Dis. 2014;46:675\u201381.","journal-title":"Dig Liver Dis."},{"key":"393_CR20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.crohns.2014.02.025","volume":"8","author":"GR D\u2019Haens","year":"2014","unstructured":"D\u2019Haens GR, Sartor RB, Silverberg MS, Petersson J, Rutgeerts P. Future directions in inflammatory bowel disease management. J Crohns Colitis. 2014;8:726\u201334.","journal-title":"J Crohns Colitis."},{"issue":"37\u201351","key":"393_CR21","first-page":"e1","volume":"148","author":"BG Levesque","year":"2015","unstructured":"Levesque BG, Sandborn WJ, Ruel J, Feagan BG, Sands BE, Colombel JF. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology. 2015;148(37\u201351):e1.","journal-title":"Gastroenterology"},{"issue":"1827\u201337","key":"393_CR22","first-page":"e2","volume":"140","author":"D Burger","year":"2011","unstructured":"Burger D, Travis S. Conventional medical management of inflammatory bowel disease. Gastroenterology. 2011;140(1827\u201337):e2.","journal-title":"Gastroenterology"},{"key":"393_CR23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2036.2008.03753.x","volume":"28","author":"R Panaccione","year":"2008","unstructured":"Panaccione R, Rutgeerts P, Sandborn WJ, Feagan B, Schreiber S, Ghosh S. Treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008;28:674\u201388.","journal-title":"Aliment Pharmacol Ther"},{"key":"393_CR24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.gastro.2015.05.036","volume":"149","author":"T Dassopoulos","year":"2015","unstructured":"Dassopoulos T, Cohen RD, Scherl EJ, Schwartz RM, Kosinski L, Regueiro MD. Ulcerative colitis care pathway. Gastroenterology. 2015;149:238\u201345.","journal-title":"Gastroenterology"},{"key":"393_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrgastro.2013.242","volume":"11","author":"ME Gerich","year":"2014","unstructured":"Gerich ME, McGovern DP. Towards personalized care in IBD. Nat Rev Gastroenterol Hepatol. 2014;11:287\u201399.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"393_CR26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2010.9","volume":"105","author":"W Afif","year":"2010","unstructured":"Afif W, Loftus EV Jr, Faubion WA, Kane SV, Bruining DH, Hanson KA, et al. Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease. Am J Gastroenterol. 2010;105:1133\u20139.","journal-title":"Am J Gastroenterol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0393-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:20:47Z","timestamp":1498335647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0393-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0393-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]}}}